Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Linehan

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Immunological Investigations|June 6, 2020
Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal AdenocarcinomaBooyeon J Han, Joseph D Murphy, Shuyang Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2009
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancerFabian Mc Johnston, Marcus C B Tan, Benjamin R Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2011
Prevention of lymphocyte apoptosis in septic mice with cancer increases mortalityAmy C Fox, Elise R Breed, Zhe Liang, et al.
Journal for Immunotherapy of Cancer|July 19, 2022
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancerJian Ye, Bradley N Mills, Shuyang S Qin, et al.
Critical Care Medicine|December 17, 2009
Cancer causes increased mortality and is associated with altered apoptosis in murine sepsisAmy C Fox, Charles M Robertson, Brian Belt, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 9, 2022
Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resectionPaul R Burchard, Yatee A Dave, Anthony P Loria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body RadiotherapyBradley N Mills, Haoming Qiu, Michael G Drage, et al.
Current Opinion in Supportive and Palliative Care|September 29, 2017
Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and SarcopeniaRichard F Dunne, Karen M Mustian, Jose M Garcia, et al.
Investigational New Drugs|July 13, 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinomaMarcus Noel, Eileen M O'Reilly, Brian M Wolpin, et al.
Cancers|January 25, 2025
Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC ModelsJian Ye, Shuyang S Qin, Angela L Hughson, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Immunological Investigations|June 6, 2020
Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal AdenocarcinomaBooyeon J Han, Joseph D Murphy, Shuyang Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2009
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancerFabian Mc Johnston, Marcus C B Tan, Benjamin R Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2011
Prevention of lymphocyte apoptosis in septic mice with cancer increases mortalityAmy C Fox, Elise R Breed, Zhe Liang, et al.
Journal for Immunotherapy of Cancer|July 19, 2022
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancerJian Ye, Bradley N Mills, Shuyang S Qin, et al.
Critical Care Medicine|December 17, 2009
Cancer causes increased mortality and is associated with altered apoptosis in murine sepsisAmy C Fox, Charles M Robertson, Brian Belt, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 9, 2022
Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resectionPaul R Burchard, Yatee A Dave, Anthony P Loria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body RadiotherapyBradley N Mills, Haoming Qiu, Michael G Drage, et al.
Current Opinion in Supportive and Palliative Care|September 29, 2017
Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and SarcopeniaRichard F Dunne, Karen M Mustian, Jose M Garcia, et al.
Investigational New Drugs|July 13, 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinomaMarcus Noel, Eileen M O'Reilly, Brian M Wolpin, et al.
Cancers|January 25, 2025
Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC ModelsJian Ye, Shuyang S Qin, Angela L Hughson, et al.
Pageof 14